
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback
May 28, 2025 01:26 am UTC| Business Technology Science
SpaceXs massive Starship rocket, central to Elon Musks vision for interplanetary travel, launched its ninth uncrewed test flight from Starbase, Texas, on May 27, 2025. The two-stage vehiclecomprising the upper-stage...

May 07, 2025 10:28 am UTC| Insights & Views Science
Mars, one of our closest planetary neighbors, has fascinated people for hundreds of years, partly because it is so similar to Earth. It is about the same size, contains similar rocks and minerals, and is not too much...
Apr 12, 2025 10:01 am UTC| Insights & Views Science
Jared Isaacman, billionaire, CEO and nominee to become the next NASA administrator, faced questions on April 9, 2025, from members of the Senate Committee on Commerce, Science, and Transportation during his confirmation...

Lab-grown meat: you may find it icky, but it could drive forward medical research
Apr 12, 2025 10:00 am UTC| Insights & Views Science
Lab-grown meat causes heated debates. Proponents see benefits for the climate and animal welfare. Opponents worry about a Frankenstein food they regard as risky and unnatural. Whatever your opinion, the technology...

Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy
Apr 11, 2025 11:14 am UTC| Politics Health Science
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global...

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment
Mar 31, 2025 15:28 pm UTC| Business Science
AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing
Mar 29, 2025 07:04 am UTC| Business Science
The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...